Market Landscaping and Sizing

A winning strategy requires deep understanding of the size, growth, segmentation, competitive dynamics, and voice-of-customer in your markets. DeciBio has the qualitative and quantitative research and analysis capabilities to give you the insights you need.

Our Experts

Stephane Budel

Andrew Aijian

Miguel Edwards

Carl Schoellhammer

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Clinical Diagnostics

MRD Monitoring Market Assessment and Strategy

A diagnostics player wanted to determine with indications / use cases to target and develop a product road map

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Market Landscaping and Sizing

VOC research, competitive assessment for a novel multi-omic technology

A ~$100M research tools and diagnostic company wanted to understand key applications and revenue potential of their novel technology to inform a go / no-go development decision

Pricing Strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Novel Technology Commercialization

Clinical Diagnostics

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

Voice-of-Customer Research

Clinical Diagnostics

IVDR Opportunity Assessment

A top-10 diagnostics company wanted to gauge preparedness and reactions to implementation of IVDR, and how that would impact a potential new product

Voice-of-Customer Research

Clinical Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Precision Medicine is evolving at a rapid pace

Discover how we can help